Molecules / Rifamycin

Rifamycin API manufacturers

CAS 6998-60-3 Updated 9 July 2026
8
manufacturers with an active filing 7 of them hold a US DMF or a CEP
3
shortage records on file across 1 countries
64
finished-dose makers across 23 regulators
Showing 8 of 8 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Lupin

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for rifamycin, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
30 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Zhejiang Changhai Pharmaceuticals

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for rifamycin, filing since 2021. Its 2023 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Olon

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 3 active US DMFs for rifamycin, filing since 2009. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.

US DMF
3 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
3 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

CKD Bio

South Korea
Makes the API

Holds 4 active US DMFs for rifamycin, filing since 2010. Its 2025 FDA inspection closed as VAI.

US DMF
4 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Euroapi France

France
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for rifamycin, filing since 2026. Its 2021 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2021 · VAI
GMP recognised in
2 markets
How this listing is sourced EDQM certificate database
View profile
08

Công ty Cổ phần Dược phẩm CPC1 Hà Nội

Vietnam
Makes the APIFinished dose

Registered with DAV (Vietnam) for rifamycin. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

5 more manufacturers hold filings for rifamycin

The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.

OlonCKD BioEuroapi FranceLuohe Nanjiecun Pharmaceutical Group PharmacyCông ty Cổ phần Dược phẩm CPC1 Hà Nội
Chat with Fred, your AI analyst

Contract manufacturers (1)

Luohe Chief Pharmaceutical China

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (7)

Sanofi France Eurofarma Laboratorios Brazil Germed Farmaceutica Ltda Brazil Natulab Laboratorio Brazil Eg S P A Italy Công ty cổ phần Tập đoàn Merap Vietnam Orbizul Farmaceutica, C.A Venezuela

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Who makes rifamycin?

Ask Fred which manufacturers are on record for rifamycin and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Also on this molecule

Shortages 3 Finished dose 7 Contract mfrs 1